Marchex (MCHX): Officer exercised options on 63K shares
Francis J Feeney, Officer at Marchex, reported an option exercise of 63K shares.
- 63K
- Shares
- Traded
- Mar 20, 2026
- Filed
- Mar 20, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jan 29, 2026Company filing · Form 8-K · Material agreement, Executive changeChanged a top executive or board member, and signed an important agreement“On January 29, 2026, the Compensation Committee of the Board of Directors of Marchex, Inc., pursuant to its review of compensation matters for executive officers, approved annual cash bonuses for fiscal year 2025 of $200,000 to Troy Hartless, Marchex’s President and Chief Revenue Officer; $150,000 to Francis Feeney, Marchex’s Chief Operating Officer, Chief Legal Officer, and Corporate Secretary; and $40,000 to Brian…”
- Feb 17, 2026Company filing · Form 8-K · Material agreement, Executive changeChanged a top executive or board member, and signed an important agreement“On February 17, 2026 (the “Grant Date”), the Compensation Committee of the Board of Directors of Marchex, Inc. (the “Corporation”), pursuant to its annual review of compensation matters, approved restricted stock units (“RSUs”) grants under the Corporation’s 2021 Stock Incentive Plan of 128,205 RSUs to Troy Hartless, Marchex’s President & Chief Revenue Officer; 96,153 RSUs to Francis Feeney, Marchex’s Chief…”
What came next
- Mar 25, 2026Company filing · Form 8-K · ResultsReported its results
- Apr 14, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
- Apr 29, 2026Company filing · Form 8-K · Material agreement, ImpairmentWrote down the value of assets, and signed an important agreement“The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference. In connection with the Company’s entry into the Sublease Agreement with RentSpree described under Item 1.01 of this Current Report on Form 8‑K, the Company determined that the carrying value of its right‑of‑use asset associated with the underlying office space exceeds its estimated fair value.”
- May 8, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
- May 13, 2026Company filing · Form 8-K · ResultsReported its results
- Jul 1, 2026Company filing · Form 8-K · Material agreement, Acquisition or saleCompleted buying or selling a business or assets, and signed an important agreement (and 3 more items)“On July 1, 2026 (the “Closing Date”), Marchex, Inc. (the “Company” or “Marchex”) consummated the previously-announced acquisition (the “Transaction”) of 100% of the outstanding shares of capital stock of Archenia, Inc. (“Archenia”) from its stockholders (the “Sellers”), which include Russell C. Horowitz, our Chairman, Michael Arends, our Vice Chairman, and another accredited investor, pursuant to that certain Stock…”
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Marchex
OQRO holds no insider, Congress, fund or contract record for Marchex dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MCHX page.
How this filing works
Explore the data
Other disclosures at Marchex
- SEC Form 4Mar 27, 2025
- SEC Form 4Mar 27, 2025
- SEC Form 4Mar 27, 2025
- SEC Form 4Nov 19, 2024
- SEC Form 4Nov 19, 2024
- SEC Form 4Nov 15, 2024
Everything OQRO holds on this company is on its MCHX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
